Experience
NeXstar Pharmaceuticals
Liposome Co.
Represented NeXstar Pharmaceuticals in declaratory judgment action regarding its Ambisome® antifungal product.
NeXstar Pharmaceuticals v. Liposome Co., 1:93-cv-00232, D. Del., Judge McKelvie
Hartig Drug Co. Inc. v. Senju Pharmaceutical Co. Ltd.
Senju Pharmaceuticals Co. Ltd.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Acura Pharmaceuticals v. Sandoz
Acura Pharmaceuticals Incorporated
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc.
AstraZeneca Pharmaceuticals LP; Shionogi Co.
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Richardson-Vicks Inc. v. American Home Products
American Home Products
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.